ATE302197T1 - Amidderivate - Google Patents
AmidderivateInfo
- Publication number
- ATE302197T1 ATE302197T1 AT01981033T AT01981033T ATE302197T1 AT E302197 T1 ATE302197 T1 AT E302197T1 AT 01981033 T AT01981033 T AT 01981033T AT 01981033 T AT01981033 T AT 01981033T AT E302197 T1 ATE302197 T1 AT E302197T1
- Authority
- AT
- Austria
- Prior art keywords
- accompanied
- amide derivative
- infection
- herpes
- hsv
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000344354 | 2000-11-10 | ||
| PCT/JP2001/009790 WO2002038554A1 (fr) | 2000-11-10 | 2001-11-08 | Derives amides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE302197T1 true ATE302197T1 (de) | 2005-09-15 |
Family
ID=18818562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01981033T ATE302197T1 (de) | 2000-11-10 | 2001-11-08 | Amidderivate |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6949543B2 (fr) |
| EP (1) | EP1340750B8 (fr) |
| JP (1) | JP3913172B2 (fr) |
| KR (1) | KR20030045180A (fr) |
| CN (1) | CN1473157A (fr) |
| AT (1) | ATE302197T1 (fr) |
| AU (1) | AU2002212734A1 (fr) |
| CA (1) | CA2428184C (fr) |
| DE (1) | DE60112790T2 (fr) |
| ES (1) | ES2247177T3 (fr) |
| WO (1) | WO2002038554A1 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003095435A1 (fr) * | 2002-05-09 | 2003-11-20 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'amides |
| TW200505894A (en) * | 2003-08-08 | 2005-02-16 | Yamanouchi Pharma Co Ltd | Tetrahydro-2H-thiopyran-4-carboxamide derivative |
| CA2536954C (fr) * | 2003-08-29 | 2012-11-27 | Exelixis, Inc. | Modulateurs c-kit et leurs procedes d'utilisation |
| JP2007523087A (ja) * | 2004-02-11 | 2007-08-16 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Ｌｘｒモジュレーターとしての化合物および組成物 |
| WO2005111013A1 (fr) * | 2004-05-13 | 2005-11-24 | Boehringer Ingelheim International Gmbh | Amides d'acide thiophene-2-carboxylique substitues, leur production et leur utilisation comme medicament |
| WO2006082821A1 (fr) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | Agent preventif ou therapeutique contre une maladie liee au virus de l'herpes |
| JP4832093B2 (ja) * | 2005-02-02 | 2011-12-07 | アステラス製薬株式会社 | テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体の製造方法 |
| ES2342558T3 (es) * | 2005-02-02 | 2010-07-08 | Astellas Pharma Inc. | Agente para prevencion/tratamiento de una enfermedad causada por un herpesvirus resistente a acyclovir. |
| CA2596850A1 (fr) * | 2005-02-02 | 2006-08-10 | Astellas Pharma Inc. | Medicament contre l'herpes genital |
| JP5011739B2 (ja) * | 2005-02-03 | 2012-08-29 | アステラス製薬株式会社 | テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物 |
| JP5128599B2 (ja) * | 2006-08-30 | 2013-01-23 | エフ．ホフマン−ラ ロシュ アーゲー | Ｇｌｙｔ−１の阻害薬 |
| US9403789B2 (en) | 2008-02-21 | 2016-08-02 | Sequoia Pharmaceuticals, Inc. | Benzofuran-containing amino acid inhibitors of cytochrome P450 |
| EP2351565A1 (fr) | 2008-10-20 | 2011-08-03 | Astellas Pharma Inc. | Médicament destiné à la prévention ou au traitement de la douleur associée à un zona |
| CN103491956A (zh) * | 2010-09-13 | 2014-01-01 | 麦克罗拜奥提斯公司 | 病毒进入哺乳动物细胞的抑制剂 |
| EP2647622B1 (fr) * | 2010-12-03 | 2017-04-19 | Fujitsu Limited | Inhibiteurs de la protéine kinésine du fuseau et leur application |
| CN103275034B (zh) * | 2013-04-16 | 2015-07-08 | 南京工业大学 | 一类小分子cathepsin D抑制剂的制备方法 |
| TW202038947A (zh) | 2018-11-28 | 2020-11-01 | 德商創新分子有限責任公司 | 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4327249B2 (ja) * | 1995-12-29 | 2009-09-09 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 抗ヘルペスウイルス性を有するフェニルチアゾール誘導体 |
| AU3289299A (en) * | 1998-02-19 | 1999-09-06 | Tularik Inc. | Antiviral agents |
| WO2000029399A1 (fr) * | 1998-11-12 | 2000-05-25 | Boehringer Ingelheim (Canada) Ltd. | Composes antiherpes |
-
2001
- 2001-11-08 ES ES01981033T patent/ES2247177T3/es not_active Expired - Lifetime
- 2001-11-08 KR KR10-2003-7006347A patent/KR20030045180A/ko not_active Application Discontinuation
- 2001-11-08 AU AU2002212734A patent/AU2002212734A1/en not_active Abandoned
- 2001-11-08 US US10/416,371 patent/US6949543B2/en not_active Expired - Fee Related
- 2001-11-08 AT AT01981033T patent/ATE302197T1/de not_active IP Right Cessation
- 2001-11-08 WO PCT/JP2001/009790 patent/WO2002038554A1/fr active IP Right Grant
- 2001-11-08 CA CA2428184A patent/CA2428184C/fr not_active Expired - Fee Related
- 2001-11-08 EP EP01981033A patent/EP1340750B8/fr not_active Expired - Lifetime
- 2001-11-08 JP JP2002541089A patent/JP3913172B2/ja not_active Expired - Fee Related
- 2001-11-08 DE DE60112790T patent/DE60112790T2/de not_active Expired - Lifetime
- 2001-11-08 CN CNA018184316A patent/CN1473157A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1340750A4 (fr) | 2004-01-21 |
| JPWO2002038554A1 (ja) | 2004-03-18 |
| AU2002212734A1 (en) | 2002-05-21 |
| CA2428184C (fr) | 2010-03-30 |
| US6949543B2 (en) | 2005-09-27 |
| EP1340750B8 (fr) | 2005-10-19 |
| ES2247177T3 (es) | 2006-03-01 |
| DE60112790T2 (de) | 2006-05-18 |
| KR20030045180A (ko) | 2003-06-09 |
| JP3913172B2 (ja) | 2007-05-09 |
| US20040034232A1 (en) | 2004-02-19 |
| EP1340750A1 (fr) | 2003-09-03 |
| DE60112790D1 (de) | 2005-09-22 |
| WO2002038554A1 (fr) | 2002-05-16 |
| EP1340750B1 (fr) | 2005-08-17 |
| CA2428184A1 (fr) | 2002-05-16 |
| CN1473157A (zh) | 2004-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112790D1 (de) | Amidderivate | |
| CY1115461T1 (el) | Παραγωγα αμιδιων | |
| ES2160046A1 (es) | Derivados pentapeptidicos. | |
| EA201270632A1 (ru) | 2'-фтор-6'-метилен карбоциклические нуклеозиды и способы лечения вирусных инфекций | |
| ES2189404T3 (es) | 1,3,4-tiadiazoles utiles para el tratamiento de infecciones por cmv. | |
| BRPI0411900A (pt) | compostos antivirais e métodos | |
| BR0008804A (pt) | 4-oxo-4, 7-dihidrotieno [2,3-b] piridina-5-carboxamidas como agentes antivirais | |
| ATE512973T1 (de) | Nukleosid-arylphosphoramidate und ihre verwendung als antivirale mittel zur behandlung von hepatitis-c-virus | |
| ATE231149T1 (de) | (1,8)-naphthyridinderivate derivate mit antiviraler wirkung | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| ES2138983T3 (es) | Uso de derivados del acido 2-(n-(2-aminoetil)amino)-acetico para el tratamiento de enfermedades condicionadas por glicosilacion no enzimatica. | |
| DE69624813T2 (de) | Robustaflavon und dessen derivate als antivirales mittel | |
| MA55020A (fr) | Dérivés d'amide utiles dans le traitement d'une infection par le virus de l'hépatite b ou de maladies induites par le virus de l'hépatite b | |
| HUP0302664A2 (hu) | Vakcináció gazdasejttel asszociált herpeszvírusok ellen | |
| NO20012834D0 (no) | Acetamid- og substituerte acetamid-holdige tioureainhibitorer for herpesvirus | |
| ES2111700T3 (es) | Derivados de cis-epoxidos, utilizables como inhibidores irreversibles de la proteasa de hiv, y procedimientos e intermediarios para su preparacion. | |
| NO20012838L (no) | Tiourea-inhibitorer for herpesvirus | |
| TR200101664T2 (tr) | Fenilendiamin grubu ieren herpesviruslarìn heteroksiklik karboksamid ieren tiore inhibitrleri | |
| ATE506367T1 (de) | Antivirale pyrimidinnukleosidderivate | |
| DE69110528T2 (de) | Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien. | |
| EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
| DE69731483D1 (de) | Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen | |
| EP1844776A4 (fr) | Agent destine a la prevention/au traitement d'une maladie causee par un virus de l'herpes acyclovir-resistant | |
| NO20012837D0 (no) | Tiourea-inhibitorer for herpesvirus | |
| NO20012836D0 (no) | Tiourea-inhibitorer for herpes virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |